KRYS
Price
$132.87
Change
+$0.84 (+0.64%)
Updated
Jun 5, 12:33 PM (EDT)
Capitalization
3.82B
67 days until earnings call
VRTX
Price
$439.70
Change
-$6.15 (-1.38%)
Updated
Jun 5, 10:46 AM (EDT)
Capitalization
114.49B
56 days until earnings call
Interact to see
Advertisement

KRYS vs VRTX

Header iconKRYS vs VRTX Comparison
Open Charts KRYS vs VRTXBanner chart's image
Krystal Biotech
Price$132.87
Change+$0.84 (+0.64%)
Volume$400
Capitalization3.82B
Vertex Pharmaceuticals
Price$439.70
Change-$6.15 (-1.38%)
Volume$2.39K
Capitalization114.49B
KRYS vs VRTX Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. VRTX commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a StrongBuy and VRTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (KRYS: $132.03 vs. VRTX: $445.85)
Brand notoriety: KRYS and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 65% vs. VRTX: 44%
Market capitalization -- KRYS: $3.82B vs. VRTX: $114.49B
KRYS [@Biotechnology] is valued at $3.82B. VRTX’s [@Biotechnology] market capitalization is $114.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 0 FA rating(s) are green whileVRTX’s FA Score has 2 green FA rating(s).

  • KRYS’s FA Score: 0 green, 5 red.
  • VRTX’s FA Score: 2 green, 3 red.
According to our system of comparison, VRTX is a better buy in the long-term than KRYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 6 TA indicator(s) are bullish while VRTX’s TA Score has 4 bullish TA indicator(s).

  • KRYS’s TA Score: 6 bullish, 2 bearish.
  • VRTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than VRTX.

Price Growth

KRYS (@Biotechnology) experienced а +7.03% price change this week, while VRTX (@Biotechnology) price change was +0.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.05%. For the same industry, the average monthly price growth was +10.91%, and the average quarterly price growth was -1.52%.

Reported Earning Dates

KRYS is expected to report earnings on Aug 11, 2025.

VRTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+5.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($114B) has a higher market cap than KRYS($3.82B). VRTX (32.76) and KRYS (31.66) have similar P/E ratio . VRTX YTD gains are higher at: 10.715 vs. KRYS (-15.722). KRYS has higher annual earnings (EBITDA): 140M vs. VRTX (-74.9M). VRTX has more cash in the bank: 6.2B vs. KRYS (617M). KRYS has less debt than VRTX: KRYS (9.66M) vs VRTX (1.65B). VRTX has higher revenues than KRYS: VRTX (11.1B) vs KRYS (333M).
KRYSVRTXKRYS / VRTX
Capitalization3.82B114B3%
EBITDA140M-74.9M-187%
Gain YTD-15.72210.715-147%
P/E Ratio31.6632.7697%
Revenue333M11.1B3%
Total Cash617M6.2B10%
Total Debt9.66M1.65B1%
FUNDAMENTALS RATINGS
KRYS vs VRTX: Fundamental Ratings
KRYS
VRTX
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
4729
SMR RATING
1..100
5791
PRICE GROWTH RATING
1..100
8962
P/E GROWTH RATING
1..100
9731
SEASONALITY SCORE
1..100
n/a32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KRYS's Valuation (70) in the Pharmaceuticals Major industry is in the same range as VRTX (77) in the Biotechnology industry. This means that KRYS’s stock grew similarly to VRTX’s over the last 12 months.

VRTX's Profit vs Risk Rating (29) in the Biotechnology industry is in the same range as KRYS (47) in the Pharmaceuticals Major industry. This means that VRTX’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's SMR Rating (57) in the Pharmaceuticals Major industry is somewhat better than the same rating for VRTX (91) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than VRTX’s over the last 12 months.

VRTX's Price Growth Rating (62) in the Biotechnology industry is in the same range as KRYS (89) in the Pharmaceuticals Major industry. This means that VRTX’s stock grew similarly to KRYS’s over the last 12 months.

VRTX's P/E Growth Rating (31) in the Biotechnology industry is significantly better than the same rating for KRYS (97) in the Pharmaceuticals Major industry. This means that VRTX’s stock grew significantly faster than KRYS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSVRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
54%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
44%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 3 days ago
59%
Declines
ODDS (%)
Bearish Trend 15 days ago
76%
Bearish Trend 15 days ago
44%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUYA3.920.09
+2.35%
HUYA
CBRE127.412.47
+1.98%
Cbre Group
BAK3.690.04
+1.10%
Braskem SA
EVGO3.890.03
+0.78%
EVgo
HTCR0.57-0.01
-1.65%
Heartcore Enterprises

VRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with KRYS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
-0.14%
KRYS - VRTX
47%
Loosely correlated
+0.86%
TECH - VRTX
40%
Loosely correlated
+2.19%
IDYA - VRTX
40%
Loosely correlated
-2.50%
CCCC - VRTX
39%
Loosely correlated
+4.05%
SNDX - VRTX
39%
Loosely correlated
-2.10%
More